FM

Frazier Management Portfolio holdings

AUM $1.12M
This Quarter Return
+9.89%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
–
AUM
$390M
AUM Growth
+$390M
Cap. Flow
+$22.8M
Cap. Flow %
5.85%
Top 10 Hldgs %
87.28%
Holding
18
New
1
Increased
2
Reduced
–
Closed
–

Top Buys

1
TBIO
Translate Bio, Inc. Common Stock
TBIO
$21.3M
2
KRYS icon
Krystal Biotech
KRYS
$805K
3
KZR icon
Kezar Life Sciences
KZR
$753K

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ANAB icon
1
AnaptysBio
ANAB
$569M
$131M 33.49% 2,316,447 – –
IOVA icon
2
Iovance Biotherapeutics
IOVA
$807M
$53.7M 13.75% 2,188,331 – –
KRYS icon
3
Krystal Biotech
KRYS
$4.27B
$36M 9.24% 895,000 +20,000 +2% +$805K
COLL icon
4
Collegium Pharmaceutical
COLL
$1.22B
$24.8M 6.36% 1,887,332 – –
GRTS
5
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$23M 5.89% 2,061,758 – –
TBIO
6
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$21.3M 5.45% +1,682,789 New +$21.3M
TPST icon
7
Tempest Therapeutics
TPST
$44M
$16.1M 4.14% 1,396,615 – –
ALNA
8
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
$13.6M 3.47% 3,330,373 – –
ALPN
9
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$10.8M 2.77% 2,571,450 – –
APTX
10
DELISTED
Aptinyx Inc. Common Stock
APTX
$10.7M 2.73% 3,190,079 – –
ITRM icon
11
Iterum Therapeutics
ITRM
$30.2M
$10.6M 2.71% 1,538,316 – –
NBRV
12
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$10.3M 2.65% 4,256,526 – –
ETTX
13
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$8.71M 2.23% 1,349,953 – –
SYBX icon
14
Synlogic
SYBX
$17M
$7.88M 2.02% 865,407 – –
SRRA
15
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$4.54M 1.16% 8,112,121 – –
KZR icon
16
Kezar Life Sciences
KZR
$28.9M
$3.61M 0.92% 467,743 +97,662 +26% +$753K
CDTX icon
17
Cidara Therapeutics
CDTX
$1.66B
$2.21M 0.57% 1,312,258 – –
BLCM
18
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$1.79M 0.46% 1,051,441 – –